Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02277184
Title Ficlatuzumab, Cisplatin and IMRT in Locally Advanced Head and Neck Squamous Cell Carcinoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Julie E. Bauman, MD, MPH
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
UPMC Presbyterian Pittsburgh Pennsylvania 15213 United States Details
Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
UPMC Shadyside Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field